June 29, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for cefepime hydrochloride 500 mg, 1 g, and 2 g base/vial for parenteral administration in the ...
June 17, 2009 — Cefepime HCl injection (Maxipime, Bristol-Myers Squibb Co) does not appear to increase the risk for death compared with comparator medications as reported previously, according to a ...
More than 2 weeks of treatment with cefepime administered by intravenous (IV) push significantly increases the risk of cefepime-induced neutropenia. A new study has demonstrated that prolonged courses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback